Canada Markets closed

Telescope Innovations Corp. (TELIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.22980.0000 (0.00%)
At close: 03:53PM EST

Telescope Innovations Corp.

1600 – 609 Granville Street
Vancouver, BC V7Y 1C3
Canada

https://www.telescopeinnovations.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Prof. Jason HeinCEO & Director49.05kN/AN/A
Mr. Robert Chisholm CPACFO & Corp. Sec.N/AN/AN/A
Paloma PrietoVP of Operations8.32kN/AN/A
Shad GrunertVP of Innovation4.85kN/AN/A
Dr. Jeffrey W. Sherman Ph.D.Chief Operating OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Telescope Innovations Corp., a chemical technology company, engages in developing synthetic processes to access pharmaceuticals for the treatment of mental health. The company is headquartered in Vancouver, Canada.

Corporate Governance

Telescope Innovations Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.